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Highlights 
x A retrospective review of Dogue de Bordeaux presenting to the cardiology 
services of two UK veterinary teaching hospitals was performed. 
x Cardiac masses and congenital heart disease, particularly subaortic stenosis, 
were identified frequently. 
x The frequency of supraventricular arrhythmia, specifically fast persistent atrial 
fibrillation, was high. 
x Atrial fibrillation was inconsistently associated with structural heart disease or 
cardiac chamber enlargement. 
x The absence of structural heart disease in some dogs with supraventricular 
arrhythmia suggests a possible primary arrhythmic mechanism. 
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Abstract 
The aim of this study was to describe the clinical phenotype of Dogue de 
Bordeaux (DdB) referred for cardiac investigation, with particular reference to the 
prevalence of atrial fibrillation and associated features. Review of canine medical 
records of two United Kingdom veterinary referral hospitals identified 64 DdB with 
available echocardiographic and electrocardiographic (ECG)/Holter data. Atrial 
fibrillation was documented in 25 (39%) dogs and supraventricular tachycardia was 
recorded in five (7.8%) dogs. In a subset of 34 dogs, excluding congenital heart disease 
(n = 17), presence of a cardiac mass (n = 7) and non-cardiac neoplasia (n = 6), 19 (56%) 
dogs had atrial fibrillation, with a median heart rate of 200 beats per min (bpm) on 
presentation. Atrial fibrillation was inconsistently associated with cardiac chamber 
remodelling, but was frequently associated with systolic dysfunction (13/19, 68.4%) 
and right sided atrial or ventricular dilatation (14/19, 73.7%) in dogs with atrial 
fibrillation in this subset. No dogs in this subset had right sided atrial or ventricular 
dilatation in the absence of supraventricular arrhythmia or systolic dysfunction. The 
absence of structural heart disease in some dogs with supraventricular arrhythmias 
suggests that an underlying primary arrhythmic process might be responsible for 
initiating remodelling, although a primary cardiomyopathy cannot be ruled out. 
 
Keywords: Canine; Dogue de Bordeaux; Cardiomyopathy; Supraventricular 
tachycardia; Subaortic stenosis 
 
Introduction 
The Dogue de Bordeaux (DdB) is a large brachycephalic breed of dog, 
originating in France. The population and cardiac pathology of DdB in the United 
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Kingdom (UK) has not been well described; however, anecdotal reports suggest that 
atrial fibrillation (AF) is prevalent in this breed and a recent study suggested that the 
breed may have a high incidence of sudden and unexpected death (McAulay et al., 
2018). The DdB is affected by a range of cardiac conditions, including subaortic 
stenosis (SAS), tricuspid dysplasia and dilated cardiomyopathy (DCM) (Borgarelli et 
al., 2006; Höllmer et al., 2008; Martin et al., 2009; Oliveira et al., 2011; Ohad et al., 
2013). A breed predisposition to supraventricular tachyarrhythmia has been suggested 
(Locatelli et al., 2011). In a study by Ohad et al. (2013), all DdB diagnosed with 
tricuspid dysplasia had AF. 
 
Atrial fibrillation has a complex pathophysiology, whereby functional and 
structural mechanisms promote electrical re-entry (Brundel et al., 2005). Atrial 
fibrillation is frequently associated with heart disease; increased atrial dimensions, 
inflammation, fibrosis, alterations in autonomic tone and ion channel expression 
promote development of AF. Large breeds of dog might be predisposed to AF because 
their atrial dimensions provide the critical atrial mass required to support wavelet re-
entry (Moore and Spear, 1987; Guglielmini et al., 2000). Atrial fibrillation in the 
absence of structural heart disease has been described as ‘lone’ AF (Menaut et al., 
2005). Frequent arrhythmia, including AF, can promote cardiac chamber remodelling 
and a dilated cardiomyopathy (DCM) phenotype, designated tachycardia-induced 
cardiomyopathy (Shinbane et al., 1997). 
 
Since AF can be a cause, or consequence, of structural or functional disease, 
clarifying the association of AF with phenotype may be helpful in defining the 
underlying disease process. This study sought to describe the phenotype of DdB within 
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a cardiac referral population, specifically with reference to the prevalence and 
associated features of AF. We hypothesised that AF is the predominant arrhythmia in 
DdBs undergoing cardiac investigation and that AF reflects a primary arrhythmia, 
rather than consequence of structural heart disease. We hypothesised that AF would 
occur in some dogs in the absence of cardiac chamber remodelling. 
 
Materials and methods 
Study group 
This study was approved by the Royal Veterinary College Ethics and Welfare 
Committee, (approval number 1296; date of approval 16th October 2014). The records 
of The Queen Mother Hospital for Animals, Royal Veterinary College, Hatfield, UK, 
and Small Animal Teaching Hospital, University of Liverpool, Neston, UK, were 
searched for DdB presenting to the cardiology services from March 2005 to July 2013. 
Dogs were excluded if echocardiographic or electrocardiographic (ECG) data were 
unavailable. 
 
Echocardiography 
Echocardiographic examinations were performed as described by Thomas et al. 
(1993), using a Vivid 7 (GE Healthcare), with simultaneous ECG recording, and 
reviewed and measured using EchoPAC Clinical Workstation Software (GE 
Healthcare). Left ventricular measurements were obtained in M-mode using the leading 
edge to leading edge method (Sahn et al., 1978). The mean of three measurements for 
dogs in sinus rhythm and five measurements for dogs with arrhythmia were recorded 
for each variable. Left ventricular systolic and diastolic measurements were normalised 
to body weight (Cornell et al., 2004). Normalised left ventricular systolic diameter 
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(LVDsn) measurements exceeding 95% confidence interval (CI) predicted values were 
defined as a marker of systolic dysfunction (LVDsn > 1.26). Normalised left ventricular 
diastolic diameter (LVDdn) measurements exceeding 95% CI predicted values were 
defined as a marker of ventricular dilatation (LVDdn >1.85). 
 
The pre-ejection period to ejection time ratio (PEP:ET) was calculated from 
Doppler interrogation of aortic flow obtained from the left apical five chamber or 
subcostal view (de Madron, 2015). Left atrial diameter was indexed to aortic diameter 
(LA:Ao) (Hansson et al., 2002). Right sided dilatation was defined as right ventricular 
diastolic dimensions exceeding 50% of the diameter of the left ventricle or right atrial 
dimensions that were subjectively larger than the left atrium in any view (Bright et al., 
2005; Menaut et al., 2005; Palermo et al., 2011). If dogs exhibited left ventricular 
dilatation, right ventricular dilatation was assessed subjectively on the basis of clinical 
experience. 
 
Pulmonary hypertension (systolic) was diagnosed when Doppler-derived 
tricuspid regurgitation velocity exceeded 3.1 m/s (> 38 mmHg) (Stepien, 2009) and 
was classified as mild (< 50 mmHg), moderate (≥ 50 mmHg to <80 mmHg) or severe 
(≥ 80 mmHg). The aortic valve, outflow tract and Doppler profile were assessed; 
velocities > 2.5 m/s were considered to be consistent with SAS (Bussadori et al., 2000; 
Höllmer et al., 2008). Pulmonic valve morphology was assessed according to Bussadori 
et al. (2000); pulmonic stenosis was defined by pulmonic velocities > 2.25 m/s. 
 
Electrocardiography 
ECG data were collected from the original ECG, Holter, echocardiographic 
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timing ECG and attending clinicians’ records. Holter data were quantitatively analysed 
by Laboratory Corporations of America, Ambulatory Monitoring Services. For initial 
analysis, AF and supraventricular tachycardia (SVT) were described collectively as 
‘supraventricular arrhythmia’ (Santilli et al., 2008). Atrial fibrillation was diagnosed 
when QRS complexes occurred without periodicity in the absence of P waves or flutter 
waves (Miller et al., 1999). Supraventricular tachycardia was defined as three or more 
QRS complexes < 0.07 s duration, occurring regularly at an instantaneous rate > 160 
beats per min (bpm), paroxysmally or persistently, and deemed to be physiologically 
inappropriate by the attending clinician or on review of Holter data with reference to 
the Holter activity diary. Dogs in sinus rhythm with no evidence of paroxysmal 
supraventricular arrhythmia on review were classed as ‘sinus rhythm’. Ventricular 
arrhythmia was described as ‘isolated’ if only individual ventricular premature 
complexes (VPCs) were identified, or ‘complex’ if couplets, triplets, bigeminy, 
trigeminy and/or ventricular tachycardia were documented. Dogs with only isolated 
VPCs on Holter were dichotomised with a cut off of 100 VPCs/24 h. 
 
Statistical analysis 
After initial assessment of the whole population, dogs with congenital heart 
disease, cardiac masses and non-cardiac neoplasia were excluded from further 
assessment, and the clinical, echocardiographic and ECG findings of the remaining 
subset (non-CHDN) were explored further. 
 
Statistical analysis was performed using Prism 6 (GraphPad Software). Data 
were assessed for normality visually and using the D’Agostino and Pearson omnibus 
normality test. Normally distributed data were expressed as mean ± standard deviation 
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(SD). Non-normally distributed data were expressed as median and inter-quartile range 
(IQR). Normally distributed, continuous data were assessed by one-way analysis of 
variance (ANOVA). Non-parametric data were compared using the Kruskal-Wallis test 
and Dunns multiple comparisons test. Fisher’s exact test was used to compare 
differences in proportions of categorical data. Statistical significance was set at P = 
0.05. 
 
Results 
The study included 64 DdB (Fig. 1). Presenting clinical signs are summarised 
in Table 1. Six of 64 (9.4%) DdB had a prior diagnosis of non-cardiac neoplasia and 
were examined to evaluate myocardial function prior to chemotherapy. Seven of 64 
(10.9%) DdB had a cardiac mass identified echocardiographically. No dogs with a 
cardiac mass had a prior diagnosis of non-cardiac neoplasia. Cardiac masses were in 
variable locations and all were suspected to be neoplastic, but only one case (with 
haemangiosarcoma) was confirmed using histopathology. Seventeen of 64 DdB were 
diagnosed with congenital defects. Twelve of 64 (18.8%) had SAS (median velocity 
3.47 m/s, IQR 2.6-5.4). Five dogs had other congenital defects, including two with 
patent ductus arteriosus, and one each with pulmonic stenosis, ventricular septal defect 
and atrial septal defect. 
 
Supraventricular arrhythmia was identified in 30/64 (46.9%) DdB, persistent 
AF in 25/64 (39.1%) and SVT in 5/64 (7.8%). Dogs with supraventricular arrhythmia 
had higher heart rates at presentation, more severe left ventricular dilatation and systolic 
dysfunction, reduced FS% and increased PEP:ET compared to dogs in sinus rhythm 
(Table 2). Dogs with supraventricular arrhythmia were more likely to have left and/or 
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right sided atrial dilatation, or left ventricular dilatation, than those in sinus rhythm (P 
= 0.001). Dogs with right sided atrial or ventricular dilatation had higher heart rates 
than those without atrial dilatation (190 ± 77 bpm versus 125 ± 52 bpm; P = 0.001). 
There was no significant difference in the frequency of supraventricular arrhythmia 
between dogs with or without SAS (P = 0.117), other congenital disease (P > 0.999), a 
cardiac mass (P = 0.433) or non-cardiac neoplasia (P = 0.1094). No dogs with a prior 
diagnosis of non-cardiac neoplasia had supraventricular arrhythmia. 
 
Systolic dysfunction was observed in 21/64 (32.8%) DdB and left ventricular 
dilatation in 13/64 (20%) DdB, occurring concurrently in 11/64 (17.2%) cases. Systolic 
dysfunction was evident in 5/34 (14.7%) DdB classified as having sinus rhythm (no 
evidence of paroxysmal supraventricular arrhythmia on review). Pulmonary 
hypertension was documented in 9/64 (14%) DdB, of which 4/9 had right sided atrial 
or ventricular dilatation. Collapse was reported in 20/64 (31.3%) DdB and was not 
associated with pulmonary hypertension (P = 0.252). Holter data were available for 
16/64 (25.0%) DdB, of which 9/16 (56.3%) had AF. Ventricular arrhythmia was 
detected in 15/64 (23.4%) DdB, of which eight had isolated VPCs and seven had 
complex arrhythmias (Table 2). Holter data were available for 13/15 (86.7%) dogs with 
ventricular arrhythmia, with a median of 105 (IQR 5-543) VPCs/24 h. In dogs with 
isolated VPCs on Holter, 6/7 (85.7%) had less than 100 VPCs/24 h. 
 
In the subset of 34 non-CHDN dogs; 19 (56%) had AF, 12 (35%) had sinus 
rhythm and three (9%) had SVT, which was paroxysmal in 2/3 dogs (median SVT 240 
bpm) (Fig. 2; Table 3). The three dogs with SVT were younger than the 31 dogs with 
other arrhythmias (P = 0.027; Fig. 3). Non-CHDN dogs with AF (n = 19) had a median 
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heart rate of 200 bpm at presentation, with 17/19 (89%) of these dogs having a heart 
rate ≥ 160 bpm. Three (15.8%) non-CHDN dogs with AF did not have any chamber 
dilatation and were considered not to have structural cardiac heart disease, although one 
was classified with systolic dysfunction. Only one of these three dogs had a heart rate 
< 160 bpm (84 bpm). Four non-CHDN dogs in sinus rhythm had systolic dysfunction, 
with 2/4 demonstrating >1000 VPCs/24 h on Holter. Overall, 18/34 (52.9%) non-
CHDN dogs demonstrated systolic dysfunction and 18/34 (52.9%) demonstrated right 
sided dilatation (atrial or ventricular), with 38% showing evidence of both systolic 
dysfunction and right sided dilatation. Of non-CHDN dogs with AF, 13/19 (68.5%) had 
systolic dysfunction and 14/19 (73.7%) had right sided dilatation. No non-CHDN dogs 
in sinus rhythm had right sided dilatation without concurrent systolic dysfunction (Fig. 
4). Left heart dilatation and systolic dysfunction were present in 9/34 (26%) non-CHDN 
dogs and five (55%) of these had AF. Normalised left ventricular dimensions and 
indexed left atrial dimensions within the non-CHDN dogs are displayed in Fig. 5. 
Pulmonary hypertension was identified in six non-CHDN dogs, four with mild and two 
with moderate severity; the latter two had AF and right sided atrial/ventricular 
dilatation. The prevalence of collapse did not differ between sinus, SVT or AF rhythm 
(P = 0.958). 
 
Discussion 
In this study supraventricular arrhythmias were detected in a high proportion of 
DdBs assessed by veterinary cardiologists at two UK referral hospitals. Atrial 
fibrillation was documented in 39% of all DdB. In the non-CHDN subset (DdB without 
congenital heart disease or neoplasia), the prevalence of atrial fibrillation was 56%. A 
previous Italian study reported AF in 3/39 (7.7%) apparently healthy DdB (Locatelli et 
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al., 2011). Since dogs in our study were drawn from a cardiology referral population 
with a high prevalence of auscultated arrhythmia and exercise intolerance, it is 
unsurprising that the prevalence of AF in our study was higher than in a general 
population; however, our findings support the hypothesis that AF is the predominant 
arrhythmia in DdB undergoing cardiac investigation in the UK. 
 
In the non-CHDN subset, 3/19 DdB with AF had a structurally normal heart. 
Atrial fibrillation in the absence of structural cardiac disease has been described as 
‘lone’ AF (Takemura et al., 2002; Menaut et al., 2005). However, the term ‘lone’ AF 
has been questioned because of inconsistent definition and improved ability to detect 
predispositions to AF (Wyse et al., 2014). Low heart rates have been reported in dogs 
with AF without structural or functional heart disease (Menaut et al., 2005). In our 
study, only one non-CHDN dog with AF without structural or functional disease had a 
heart rate < 160 bpm on presentation. Whether fast AF rates at presentation reflect more 
advanced underlying disease, stress or a breed propensity to tachyarrhythmia remains 
unclear. 
 
Nine of 34 (26%) non-CHDN DdB had increased left heart dimensions and 
systolic dysfunction, consistent with a dilated cardiomyopathy (DCM) phenotype, and 
5/9 (55%) of these dogs had AF. DCM has been characterised by systolic and diastolic 
dysfunction, and variable ventricular dilatation (Kittleson, 1998; Tidholm et al., 2001), 
which can precipitate valvular incompetence, atrial dilatation and arrhythmias, 
particularly AF (Dukes-McEwan et al., 2003). The prevalence of AF in a previous 
retrospective study of DCM was 45%, with a high prevalence in the Irish wolfhound, 
Great Dane and Newfoundland (Tidholm and Jönsson, 1996; Vollmar, 2000; Meurs et 
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al., 2001a; Martin et al., 2009). DCM has been reported previously in the DdB; 
however, the inconsistent relationship of AF to the DCM phenotype in this population 
suggests that left ventricular dilatation does not always precede development of AF. 
 
Atrial fibrillation occurs frequently in the Irish wolfhound, with and without 
DCM, and is reported in up to 87.6% of Irish wolfhounds with a diagnosis of DCM 
(Vollmar, 2000). Studies in Irish wolfhounds support an association between AF and 
DCM, which develops in the majority of dogs with AF (Simpson et al., 2016). Whether 
DCM in the Irish wolfhound reflects a primary cardiomyopathy, atrial dysfunction or 
sustained tachycardia is unclear (Brownlie and Cobb, 1999). Familial DCM associated 
with early AF has been reported in human beings (Sébillon et al., 2003), but sustained 
tachyarrhythmia, including AF, may result in biventricular systolic dysfunction and 
eccentric dilatation (Wilson et al., 1987; Shinbane et al., 1997; Schoonderwoerd et al., 
2001; Dukes-McEwan et al., 2003). 
 
A feature of DdBs in this study was the high frequency of right sided atrial or 
ventricular dilatation, which were evident in 27/64 (42.1%) of all dogs and over half of 
non-CHDN dogs in the absence of severe pulmonary hypertension. In a retrospective 
study of DCM in the Irish wolfhound, predominantly right sided dilatation was reported 
in 5.4% dogs and right sided changes only in 4.2% of dogs (Vollmar, 2000). 
 
Right ventricular dilatation has been associated with arrhythmogenic right 
ventricular cardiomyopathy (ARVC) in dogs. In retrospective studies of Boxer 
cardiomyopathy, 21.5-43% of dogs had right ventricular dilatation (Basso et al., 2004; 
Palermo et al., 2011). It is possible DdB in this study were affected by a 
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cardiomyopathy with a predisposition for right sided pathology. A hallmark of ARVC 
is frequent ventricular arrhythmia, often with complexity, including couplets, triplets 
and ventricular tachycardia (Meurs et al., 1999; Basso et al., 2004; Palermo et al., 
2011). In our study, 15/64 (23.4%) DdBs had documented ventricular arrhythmia; 
however, since Holter was inconsistently performed, ventricular arrhythmia might have 
been under-diagnosed. Alternatively, given the high frequency of DdB with AF in our 
study, some supraventricular QRS complexes may have been erroneously classified as 
ventricular because of intermittent aberrant conduction with bundle branch block, 
despite manual Holter review. Ventricular arrhythmia has been documented in 32% of 
apparently normal dogs (Meurs et al., 2001b), with normal Dobermans and Boxers 
reportedly having a ventricular burden < 50 and < 91VPCs/24 h, respectively (Stern et 
al., 2010; Wess et al., 2010). On the basis of a dichotomised cut-off of 100 VPCs/24 h, 
approximately half of the DdB with ventricular arrhythmia in our study had isolated 
arrhythmia of a low frequency. 
 
Atrial fibrillation has been described previously in DdBs with tricuspid 
dysplasia (Ohad et al., 2013). Tricuspid dysplasia in dogs has been defined by 
echocardiographic characteristics including leaflet thickening, tethering and valvular 
insufficiency, as assessed by right atrial dilatation and regurgitant jet area (Bonagura et 
al., 1999; Oyama and Sisson, 2001; Ohad et al., 2013). In human beings, functional 
tricuspid insufficiency due to annular distortion and alterations in papillary muscle 
geometry has been reported to be secondary to right and left ventricular dilatation, 
systolic dysfunction and respiratory phase (Rogers and Bolling, 2009; Topilsky et al., 
2014; Tornos Mas et al., 2015). The assessment of tricuspid insufficiency by regurgitant 
jet area has been discouraged because of technical limitations (Lancellotti et al., 2010). 
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Alterations in papillary muscle geometry result in the echocardiographic appearance of 
leaflet tethering and reduced valvular coaptation (Spinner et al., 2012). In human beings 
with chronic AF in the absence of organic heart disease, the development and severity 
of tricuspid regurgitation has been associated with AF type and duration (Najib et al., 
2011; Park et al., 2015). In view of the unknown influence of these factors in dogs, we 
could not confidently define normal or dysplastic tricuspid morphology and only 
described right sided dilatation. Although many DdBs with AF displayed right sided 
atrial or ventricular dilatation and systolic dysfunction, no non-CHDN dogs had right 
sided dilatation without supraventricular arrhythmia or systolic dysfunction (Fig. 4). 
This observation suggests that right sided dilatation might reflect cardiac dysfunction 
rather than primary valvular disease in some DdBs. 
 
Five dogs in our study had supraventricular tachycardia (one persistent and four 
paroxysmal). Although the number of dogs with SVT was small, the three non-CHDN 
dogs with SVT were younger than dogs with sinus rhythm and AF. In dogs, SVT has 
been associated with structural heart disease and systemic disease (Kittleson, 1998; 
Finster et al., 2008). Atrial pathology predisposing to supraventricular arrhythmia has 
been described in association with ARVC (Fox et al., 2000; Basso et al., 2004; Mano 
et al., 2013; Vila et al., 2017), and SVT has been reported in Boxers with ARVC 
(Baumwart et al., 2005). In human beings, paroxysmal SVT is closely associated with 
paroxysmal AF and it has been suggested that SVT might predispose to AF 
development because of atrial stretch, reduced atrial refractoriness and vagal activation 
during tachycardia (Chang et al., 2008). Focal atrial tachycardia (FAT) was reported in 
two DdB in a series of 16 dogs diagnosed with FAT by electrophysiological study 
(Santilli et al., 2010). Seven of these dogs had a surface ECG diagnosis of AF. The 
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authors noted that FAT occurred in younger dogs, as reported in this study, and that 
FAT predominantly originated within the right atrium. Of the three non-CHDN dogs 
with SVT in our study, 2/3 had right sided dilatation potentially supportive of right 
sided pathology (Figs. 4 and 5). Although our study cannot clarify any temporal 
relationship between arrhythmia types, it is possible that SVT might precede and 
degenerate into AF in some DdB. 
 
Additional findings in this retrospective study included the identification of 
cardiac masses in 7/64 (10.9%) DdB and increased aortic velocities, consistent with 
SAS, in 12/64 (18.8%) DdB. The high prevalence of increased aortic velocities is 
consistent with Danish and Israeli studies, which reported subaortic stenosis in 17% 
and 24% of DdBs in screened and referral populations, respectively (Höllmer et al., 
2008; Ohad et al., 2013). 
 
Our study has several limitations, inherent in any retrospective studies. The 
inclusion of dogs with concurrent disease might influence heart rate and rhythm, and 
no account was taken of the potential influence of medications on heart rate or cardiac 
dimensions. We elected to use normalised left ventricular M-mode measurements and 
defined values exceeding 95% CI predicted values to categorise left ventricular 
dimensions and systolic function because of the availability of these images. There are 
acknowledged limitations of M-mode measurements and it would have been preferable 
to have assessed left ventricular dimensions and function by calculation of end systolic 
volume index using Simpson’s method of discs (Lang et al., 2005; Tidholm et al., 
2010). The use of 95% CI predicted values determined by the Cornell method may be 
insensitive because of the wide prediction intervals. Quantitative evaluation of right 
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sided dimensions would have been preferable; however, the retrospective nature of this 
study meant that images optimised for right sided evaluation were rarely available. Our 
inability to more clearly define the presence and magnitude of right sided dilatation is 
a substantial limitation. 
 
Holter ECG was inconsistently available and this may have limited our ability 
to obtain representative heart rates. Some cases presenting with sinus rhythm may have 
had unidentified paroxysmal supraventricular arrhythmia, predisposing to systolic 
dysfunction or chamber dilatation; our definition of SVT may include some dogs with 
sinus tachycardia. No cases had an electrophysiological study to clarify the mechanism 
of arrhythmia, so some rhythms may have been misclassified on surface ECG. 
 
Conclusions 
In this UK referral population of DdB, cardiac masses and subaortic stenosis 
were relatively frequent. The prevalence of supraventricular arrhythmia, specifically 
fast AF with ventricular response rate exceeding 160 bpm, was high. Atrial fibrillation 
was associated with cardiac chamber dilatation in the majority of dogs. Most dogs with 
atrial fibrillation had right sided dilatation and systolic dysfunction; however, this was 
inconstantly associated with left ventricular dilatation or a DCM phenotype. After 
excluding dogs with congenital heart disease and neoplasia, no remaining dogs had 
right sided dilatation in the absence of supraventricular arrhythmia or systolic 
dysfunction. In view of the subjective classification of right sided dilatation in this 
retrospective study, any inferences drawn from these observations should be viewed 
cautiously. Potential aetiologies include primary cardiomyopathy with right sided 
predilection and/or predisposition to supraventricular arrhythmia with cardiac 
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remodelling secondary to tachycardia-induced cardiomyopathy. Since some 
cardiomyopathies may be associated with a propensity for supraventricular arrhythmia, 
these mechanisms may not be mutually exclusive. Serial echocardiographic and Holter 
studies may help to clarify if supraventricular arrhythmia typically develops as a 
consequence of chamber dilatation, or if it precedes cardiac chamber remodelling in the 
DdB, and whether the findings from this small study are representative of the wider 
DdB population. 
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Sinus rhythm  
n = 34 
 
Figure legends 
 
Fig. 1. Summary of 64 Dogue de Bordeaux (DdB) presented for cardiac evaluation. 
RVC, Royal Veterinary College, UoL, University of Liverpool. 
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Fig. 2. Summary of congenital heart disease, cardiac mass and non-cardiac neoplasia 
(CHDN) in the study group of Dogue de Bordeaux (DdB) and development of subset 
of dogs without congenital heart disease, cardiac mass and non-cardiac neoplasia (non-
CHDN). SAS, subaortic stenosis. 
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Fig. 3. Scatter plot of age associated with rhythm diagnosis in subset of 34 Dogue de 
Bordeaux (DdB) without congenital heart disease, cardiac mass or non-cardiac 
neoplasia (non-CHDN). AF, atrial fibrillation; SVT, supraventricular tachycardia. 
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Fig. 4. Systolic dysfunction and right sided dilatation associated with rhythm diagnosis 
in subset of 34 Dogue de Bordeaux (DdB) without congenital heart disease, cardiac 
mass or non-cardiac neoplasia (non-CHDN). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
  
Atrial fibrillation 
 
 
n = 19 Systolic 
dysfunction 
 
 
 
 
n = 2 
Systolic 
dysfunction 
and right-
sided 
dilatation 
 
n = 2 
Right-sided 
dilatation 
 
 
 
 
n = 0 
Systolic 
dysfunction 
 
 
 
 
n = 3 
DdB with no congenital heart disease, cardiac 
mass or non-cardiac neoplasia (non-CHDN) 
 
n = 64 
Systolic 
dysfunction 
 
 
 
 
n = 0 
Sinus rhythm 
 
 
n = 12 
Supraventricular 
tachycardia 
 
n = 3 
Systolic 
dysfunction 
and right-
sided 
dilatation 
 
n = 10 
Systolic 
dysfunction 
and right-
sided 
dilatation 
 
n = 1 
Right-sided 
dilatation 
 
 
 
 
n = 1 
Right-sided 
dilatation 
 
 
 
 
n = 4 
AC
CE
PTE
D M
AN
US
CR
IPT
 27 
Fig. 5. Box and whisker plots of (a) left atrial-to-aortic ratio (LA:Ao); (b) normalised 
left ventricular systolic dimension (LVIDsn); (c) normalised left ventricular diastolic 
dimension (LVIDsn) according to rhythm diagnosis in subset of 34 Dogue de Bordeaux 
(DdB) without congenital heart disease, cardiac mass or non-cardiac neoplasia (non-
CHDN). a            b            c  
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Table 1 Signalment and presenting clinical signs in study group of 64 Dogue de Bordeaux. 
 
 n 
Signalment  
Age (Years) 4.3 ( ± 2.1) 
Sex (Male:Female) 49:15 
Weight (kg) 57.1 ( ± 8.4) 
Clinical signs  
Auscultated arrhythmia 33 (51.6%) 
Exercise intolerance 26 (41%) 
Anorexia 24 (37.5%) 
Systolic murmur 21 (32.8%) 
Dyspnoea 21 (32.8%) 
Collapse  20 (31.3%) 
Abdominal distension 16 (25%) 
Weight loss 16 (25%) 
Cough 7 (10.9%) 
Gallop sound 1 (1.6%) 
 
Normally distributed data expressed as mean ± standard deviation (SD).  
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Table 2 Signalment and echocardiographic and electrocardiographic findings in 64 Dogue de Bordeaux 
with sinus rhythm and supraventricular arrhythmia. 
 
 Sinus rhythm Supraventricular arrhythmia P value 
Presentation    
Number of cases 34 30  
RVC cases:UoL cases 20:14 23:7 0.183 
Age (Years) 4.7 ± 2.34 3.9 ± 2.0 0.13 
Sex (Male:Female) 25:9  24:6  0.571 
Weight (kg) 56.3 ± 7.1 58.1 ± 9.7 0.387 
HR Presentation  104 [84-129] 190 [120-240] < 0.001 
History of collapse or syncope 10/24 (29.4%) 10/20 (33.3%) 0.791 
Echocardiography    
LA/Ao 1.31 [1.18-1.50] 1.8 [1.48-2.06] < 0.001 
LVDdn 1.5 ± 0.34 1.71 ± 0.37 0.032 
LVDsn 1.00 ± 0.30 1.34 ± 0.34 0.002 
FS% 28.6 ± 9.9 15.0 ± 9.0 < 0.001 
PEP:LVET 0.41 ± 0.10 0.57 ± 0.13 < 0.001 
TRV (m/s) 2.8 [2.6-3.1] 2.9 [2.3-3.0] 0.912 
Right sided dilatation 6/27 (18.1%) 21/8 (72%) 0.001 
No remodelling (No LVD, LAD or RSD)  23 (67%) 4 (13.3%) 0.007 
Rhythm    
HR ECG/Holter mean 80 [68-125] 135 [98-240] 0.032 
Ventricular arrhythmia 5  10  0.138 
Complex ventricular arrhythmia (couplets, triplets bigeminy, 
trigeminy and/or ventricular tachycardia) 
4  3 > 0.999 
Specific diagnosis    
SAS 9 (26.5%) 3 (10%) 0.119 
CHD (not SAS) 3 (8.8%) 2 (6.7%) > 0.999 
Cardiac mass 5 (14.7%) 2 (6.7%) 0.433 
Non-cardiac neoplasia 6 (17.6%) 0 (0%) 0.016 
 
Normally distributed data expressed as mean ± standard deviation (SD) and non-normally distributed data are 
expressed as median [inter-quartile range]. 
RVC, Royal Veterinary College; UoL, University of Liverpool; HR, heart rate; LA, left atrial diameter; Ao, aortic 
diameter; LVDdn, left ventricular diameter diastole normalised; LVDsn, left ventricular diameter systole 
normalised; FS, fractional shortening; PEP, pre-ejection period; ET, left ventricular ejection time; TRV, tricuspid 
regurgitant velocity; LVD, left ventricular dilatation; LAD, left atrial dilatation; RSD, right sided dilatation; SAS, 
subaortic stenosis.  
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Table 3 Signalment, echocardiographic and electrocardiographic findings in subset of Dogue de 
Bordeaux excluding congenital heart disease, cardiac mass and non-cardiac neoplasia. 
 
 Sinus AF SVT P value 
Signalment     
n 12 19 3  
Age (Years) 4.9 [3.1-6.2] 4.1 [3.1-5.6] 1.5 [1-2.3] 0.027  
Sex (Male:Female) 10:2 15:4 2:1 (66.6% Male) 0.813 
Weight (kg) 53.5 [48.4-54.7] 61.9 [52.9-67.6] 50.2 [45.1-66.0] 0.153 
HR presentation  128 [120-170] 200 [160-240] 120 [84-360] 0.054 
History of collapse or 
syncope 
5 (41%) 8 (42.1%) 1 (33.3%) 0.959 
Echocardiography     
LA/Ao 1.39 [1.21-1.56] 1.83 [1.59-2.16] 1.31 [1.27-1.33] a 0.004  
LVDdn 1.42 [1.25-2.05] 1.37 [1.27-1.57] 1.47 [1.4-1.55] 0.324 
LVDsn 1.04 [0.83-1.51] 1.37 [1.27-1.57] 1.14 [1.02-1.26] 0.298 
FS (%) 25.3 [16.4-28.0] 11.7 [7.81-21.1] 16.5 [11.9-21.0] a 0.017  
PEP:LVET 0.48 [0.36-0.57] 0.57 [0.54-0.69] 0.41 [0.4-0.57] a 0.017  
TRV (m/s) 2.58 [2.58-3.00] 3 [2.4-3.3] 2.9 [2.8-3.0] 0.79 
Left-sided dilatation 4 (33.3%) 5 (26.3%) 0 (0%) 0.504 
Right sided dilatation 2 (16.7%) 14 (73.7%) 2 (66.6%) 0.007 
 
Data are expressed as median [interquartile range]. AF, atrial fibrillation; SVT, supraventricular 
tachycardia; HR, heart rate; LA, left atrial diameter; Ao, aortic diameter; LVDdn, left ventricular 
diameter diastole normalised; LVDsn, left ventricular diameter systole normalised; FS, fractional 
shortening; PEP, pre-ejection period; ET, left ventricular ejection time; TRV, tricuspid regurgitant 
velocity. Groups were compared with a Kruskal-Wallis test and the P value is reported with pair-wise 
comparisons using Dunn’s multiple comparisons test. 
a Within each row, data that were not significantly different between the two indicated groups. 
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